Survival outcomes of poorly differentiated colorectal carcinoma variants: Insights from a single teaching institute☆

被引:0
|
作者
Xu, Zhengfan [1 ]
Theisen, Brian K. [1 ,2 ]
Chang, Qing [1 ]
Schultz, Daniel [1 ]
Ahsan, Beena U. [1 ,2 ]
机构
[1] Henry Ford Hlth, Detroit, MI 48202 USA
[2] Michigan State Univ, Coll Human Med, E Lansing, MI USA
关键词
MEDULLARY CARCINOMA; MICROSATELLITE INSTABILITY; LARGE-BOWEL; ADENOCARCINOMA; COLON; CANCER;
D O I
10.1016/j.humpath.2024.105710
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The morphologic diagnosis of colorectal carcinoma (CRC) is typically straight forward. However, there are certain subtypes of CRC that pose diagnostic challenges for daily practice due to sometimes overlapping morphologic and immunohistochemical features. These subtypes include poorly differentiated adenocarcinoma NOS, in the absence of conventional morphology (PDA-NOS), large cell neuroendocrine carcinoma (LCNEC), medullary carcinoma (MC), undifferentiated carcinoma (UC) and lymphoepithelioma-like carcinoma (LELC). This study aims to see if there is a survival difference between poorly differentiated variants of CRC, as well as other clinicopathological features that may affect prognosis. Additionally, we analyzed interobserver agreement among gastrointestinal pathologists (GP) at our institution in subclassifying poorly differentiated CRC. All consecutive patients with the diagnoses of PDA-NOS, MC, LCNEC, UC and LELC between July 2018 and July 2023 were included. Cox proportional regression test was used for multivariate analysis, while log-rank and Kaplan-Meier tests were used for univariate and survival analyses. Out of the same cohort of patients, 58 samples identified and reviewed by 3 GI-subspecialty-trained pathologists who were asked to assign the cases as PDANOS, LCNEC, MC, UC and LELC. Interobserver agreement was analyzed using Fleiss Kappa. Of the total 77 patients, 63 were PDA-NOS, 3 were LCNEC, 6 were MC, 4 were UC and 1 was LELC patients. Multivariate analysis using Cox proportional regression showed that tumor size (p = 0.001, HR = 1.22, 95% CI 1.08-1.38), patient age (p = 0.001, HR 1.73, 95% CI 1.24-2.40), and M stage (p = 0.02, HR 2.22, 95% CI 1.14-4.32) were significantly associated with worse OS. For the 58 cases analyzed, 3 GP agreed on 42 (72%) cases. The most common diagnosis was PDA-NOS and for 33 (57%) agreement was unanimous. There was moderate agreement (k 0.41-0.60) between all 3 GP. Our study evaluated the challenges associated with histological evaluation of colon cancers with poorly differentiated morphologies. Among the diagnoses considered in the study, MC and LCNEC had different prognostic implications compared to PDA-NOS and UC. Additionally, our GP showed moderate interobserver agreement, indicating that some level of variability in diagnosing poorly differentiated CRC subtypes may be inevitable.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The story of poorly differentiated thyroid carcinoma: From Langhans' description to the Turin proposal via Juan Rosai
    Volante, Marco
    Bussolati, Gianni
    Papotti, Mauro
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2016, 33 (05) : 277 - 283
  • [42] BRAF and NRAS Locus-Specific Variants Have Different Outcomes on Survival to Colorectal Cancer
    Summers, Matthew G.
    Smith, Christopher G.
    Maughan, Timothy S.
    Kaplan, Richard
    Escott-Price, Valentina
    Cheadle, Jeremy P.
    CLINICAL CANCER RESEARCH, 2017, 23 (11) : 2742 - 2749
  • [43] Insights from a retrospective study: an understanding of pediatric colorectal carcinoma
    Guzman, Sofia Brenes
    Garcia, Edgar Fernando Oliver
    Rojas, Edgar Guillermo Lazcano
    Tinajero, Alfa Guadalupe Barraza
    Meza, Daniela Hernandez
    Chavez, Jose Luis Gonzalez
    Camacho, Edgar Melo
    Enriquez, Juan Carlos Nunez
    EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE, 2024, 72 (01)
  • [44] Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single Institute
    Oh, Eun Sang
    Moon, Sung Ho
    Lee, Youngjoo
    Ahn, Beung-Chul
    Lee, Jong Yeul
    Suh, Yang-Gun
    Chung, Joo-Hyun
    Kim, Moon Soo
    Lee, Jong Mog
    Choi, Jin-Ho
    Kim, Tae Hyun
    CANCERS, 2023, 15 (23)
  • [45] A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma
    Nagumo, Yoshiyuki
    Kojima, Takahiro
    Shiga, Masanobu
    Kandori, Shuya
    Kimura, Tomokazu
    Takaoka, Ei-ichiro
    Onozawa, Mizuki
    Miyazaki, Jun
    Kawai, Koji
    Ishikawa, Hitoshi
    Sakurai, Hideyuki
    Nishiyama, Hiroyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 354 - 361
  • [46] Disease-Free Overall Survival in Patients Operated for Poorly Differentiated Squamous Cell Carcinoma: A Research Protocol for a Retrospective Cohort Study
    Banga, Bhawna
    Kambala, Rajanikanth
    Bhola, Nitin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2025, 19 (02) : 12 - 14
  • [47] INCREASED GLYPICAN-3 IMMUNOSTAINING IS ASSOCIATED WITH LONGER SURVIVAL OUTCOMES IN COLORECTAL CARCINOMA
    Al-Maghrabi, Jaudah
    Al-Mansouri, Zuhoor
    Al-Harbi, Abdullah
    Assidi, Mourad
    Buhmeida, Abdelbaset
    Gomaa, Wafaey
    POLISH JOURNAL OF PATHOLOGY, 2022, 73 (01) : 14 - 20
  • [48] Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival
    Benzerdjeb, Nazim
    Traverse-Glehen, Alexandra
    Philouze, Pierre
    Bishop, Justin
    Devouassoux-Shisheboran, Mojgan
    HISTOPATHOLOGY, 2020, 76 (04) : 581 - 591
  • [49] Emergency management of a patient with severe airway obstruction resulting from poorly differentiated thyroid carcinoma: A case report
    Yang, Rong
    Yu, Xiongfei
    Ma, Liang
    Wu, Fusheng
    ONCOLOGY LETTERS, 2012, 4 (04) : 771 - 774
  • [50] Carcinoma cervix: A single institute experience from Kashmir, Northern India
    Nasreen, Shahida
    Lone, Aabid R.
    Manzoor, Arshad
    Dar, Showket A.
    Banday, Saquib Z.
    Nuzhatu, Nazia
    Rasool, Malik T.
    Andleeb, Asifa
    Wani, Shaqul Q.
    Fatima, Kaneez
    Sofi, Mushtaq A.
    Hussain, Shaiba
    Dar, Nazir Ahmad
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1407 - 1411